Section Arrow
ORIC.NASDAQ
- Oric Pharmaceuticals
Quotes are at least 15-min delayed:2026/10/20 19:46 EDT
Regular Hours
Last
 13.78
+1.06 (+8.33%)
Day High 
14.3099 
Prev. Close
12.72 
1-M High
14.12 
Volume 
2.02M 
Bid
12.9
Ask
14.5
Day Low
12.52 
Open
12.79 
1-M Low
10.925 
Market Cap 
1.32B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.06 
20-SMA 12.55 
50-SMA 12.95 
52-W High 14.68 
52-W Low 7.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.30/-1.85
Enterprise Value
1.32B
Balance Sheet
Book Value Per Share
3.68
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
EYPTEyePoint Inc.0.4052-0.0348-7.91%-- 
RXRXRecursion Pharmaceuticals3.66+0.05+1.39%-- 
MRNAModerna242.08+15.19+6.69%-- 
IBRXImmunityBio8.77+0.35+4.16%-- 
SLNSilence Therapeutics Plc19.61+0.03+0.15%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.